(3 Minutes Read)
The World Health Organisation (WHO) has said the capacity of the current manufacturers of Mpox vaccine cannot meet global demand unless there is some form of intervention to scale up production. WHO reports on the Mpox disease spread still showed that the epicenter for the new emergency of international concern was in Central Africa and neighbouring countries.
The World Health Organisation (WHO) has said the capacity of the current manufacturers of Mpox vaccine cannot meet global demand unless there is some form of intervention to scale up production. WHO reports on the Mpox disease spread still showed that the epicenter for the new emergency of international concern was in Central Africa and neighbouring countries. The WHO Country Director in Nigeria, Dr. Walter Mulombo, stated this in Abuja while giving an update on efforts being made to control the virus. The situation in Nigeria, Mulombo said, was presently not at high risk. It’s a moderate risk, but one needs to continue to remain vigilant since cases reported as far as Europe or Asia and Nigeria are not safe until this overall event is safe. WHO will continue to work with the government to strengthen public health measures that are needed to control the outbreak. Nigeria will be receiving a number of doses of vaccine through donations from the U.S. government. The needs globally are huge. The vaccine is in short supply, and the capacity of the current manufacturer cannot meet the global demand unless some kind of intervention is there.
National Primary Healthcare Development Agency’s (NPHCDA) vaccination strategy, which is in line with the recommendation of WHO to target the people at highest risk and those who have the disease and their contacts as well as their workers. The WHO director said laboratories in Nigeria would be optimised to get the patients tested if more spread of the virus is reported. Nigeria is building on a system that’s already strong as a result of exposure to the COVID-19 pandemic and the country has a lot of molecular labs. It’s just a matter of scaling a bit the capability that is within Nigeria’s reach anyway.
Read Also:
https://trendsnafrica.com/global-concern-on-mpox-as-it-spreads-beyond-africa/
https://trendsnafrica.com/drc-to-get-mpox-vaccines/
The Nigeria Centre for Disease Control (NCDC) said the country currently has 40 confirmed cases of Mpox with no deaths out of 830 suspected cases. The cases were found in about 13 states including Ogun, Lagos, South-South, South East, and Northern parts of the country. It said that all the cases of Mpox in Nigeria are the class 2B type, the less serious one.
